Argent Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Argent Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-553,472	Closed	-$27.8M	–	204
2016 Q2	$27.8M	Sell	553,472 -5,400	-1%	-$287K	1.24%	30
2016 Q1	$29.9M	Sell	558,872 -236,915	-30%	-$13.9M	1.36%	31
2015 Q4	$52.2M	Sell	795,787 -300,420	-27%	-$18.6M	2.43%	11
2015 Q3	$61.9M	Buy	1,096,207 +6,835	+0.6%	+$443K	3.09%	4
2015 Q2	$64.4M	Sell	1,089,372 -5,818	-0.5%	-$359K	2.95%	8
2015 Q1	$68.2M	Buy	1,095,190 +272,912	+33%	+$15.9M	3.09%	5
2014 Q4	$47.3M	Buy	822,278 +72,847	+10%	+$4.06M	2.27%	17
2014 Q3	$40.3M	Buy	749,431 +219,491	+41%	+$11.6M	2.21%	17
2014 Q2	$27.8M	Buy	+529,940	New	+$27.1M	1.48%	29

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Argent Capital Management's TEVA Position: Q3 2016 in Review

Argent Capital Management sold out of Teva Pharmaceuticals (TEVA) in Q3 2016, closing a stake of 553,472 shares — an estimated $27.8M sold.

Argent Capital Management first reported a position in TEVA in Q2 2014 and held it in 9 quarters. The position peaked at $68.2M in Q1 2015. 798 funds tracked by Wall St. Rank hold TEVA as of Q3 2016.

Argent Capital Management reported no remaining Teva Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
Argent Capital Management sold 553,472 Teva Pharmaceuticals shares in Q3 2016, an estimated $27.8M.
Argent Capital Management first reported a position in Teva Pharmaceuticals in Q2 2014 and held it in 9 quarters.
Argent Capital Management's Teva Pharmaceuticals position peaked at $68.2M in Q1 2015.
798 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2016.

Based on Argent Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.